Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis
Crossref DOI link: https://doi.org/10.1186/1546-0096-13-S1-P166
Published Online: 2015-09-28
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ishigatsubo, Y
Takeno, M
Kirino, Y
Mizuki, N
Article History
First Online: 28 September 2015